Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco-regional control?

This prospective study aimed to estimate the efficacy of sorafenib therapy after transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC). Between July 2011 and March 2013, 17 patients were enrolled, 11 of whom received sorafenib therapy. Patients who previously receive...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: Tamai, Tsutomu, Kumagai, Kotaro, Sakae, Haruka, Onishi, Hiroka, Tabu, Kazuaki, Tabu, Eriko, Muromachi, Kaori, Saishoji, Akiko, Oda, Kohei, Mawatari, Seiichi, Moriuchi, Akihiro, Sakurai, Kazuhiro, Ido, Akio
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2017
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740826/
https://ncbi.nlm.nih.gov/pubmed/29285389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1434
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky